Archives of Science
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Arch Sci 7: 167,
  • DOI: 10.4172/science.1000167

Identification of Metastatic Niches in Patients with High-Grade Neuroendocrine Tumors

Luciana Carvalheira*
Department of Radiology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, United States
*Corresponding Author : Luciana Carvalheira, Department of Radiology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, United States, Email: Carvalheira344@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 31, 2023

Abstract

Metastasis is a critical determinant of prognosis and treatment strategies in patients with high-grade neuroendocrinetumors (NETs). The identification of metastatic niches within the body is essential for accurate staging and personalizedtherapy. Traditional imaging techniques have limitations in detecting small metastases and differentiating them from benign lesions. In this context, nuclear medicine sequence imaging, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), has emerged as a promising tool. This article provides anoverview of the latest advancements in the identification of metastatic niches in high-grade NETs. Specifically, the use oftriple-positive radiolabelled molecular probes in nuclear medicinesequence imaging is highlighted. These probes targetmultiple biomarkers expressed on high-grade NET cells, enhancing specificity and reducing false-positive results. By accurately identifying metastatic niches, clinicians can optimize treatment decisions and offer targeted therapies suchas peptide receptor radionuclide therapy (PRRT) or selective internal radiation therapy (SIRT). The identification ofmetastatic niches through nuclear medicine sequence imaging holds significant clinical implications, improving staging accuracy, treatment planning, and monitoring of disease progression. Further research in this field promises to advanceour understanding and management of high-grade NETs, ultimately improving patient outcomes.

Citation: Carvalheira L (2023) Identification of Metastatic Niches in Patients withHigh-Grade Neuroendocrine Tumors. Arch Sci 7: 167. Doi: 10.4172/science.1000167

Copyright: © 2023 Carvalheira L. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top